Gaelle Pierron

31PUBLICATIONS
439CO-AUTHORS
Molecular targetsInfant and child healthPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Nov 04, 2026
Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients With TP53, STAG2, and CDKN2A Alterations.

|Sep 10, 2026
Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study.

|Aug 10, 2026
DNMT3B Plays Antagonistic Roles with SMARCB1 and Is a Targetable Vulnerability in Rhabdoid Tumors.

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

Pageof 6

Frequent Collaborators

12 joint publications

Gudrun Schleiermacher

9 joint publications

Didier Surdez

9 joint publications

Olivier Delattre

8 joint publications

Marc-Henri Stern